title: Paradoxical Response to Enzyme Replacement Therapy of Fabry Disease Cardiomyopathy.
authors.affiliation: From the Department of Cardiovascular, Respiratory, Nefrologic and Geriatric Sciences, La Sapienza University, Rome, Italy (A.F., C.C.); and Mebic Consortium, San Raffaele University, Rome, Italy (M.A.R.). biocard@inmi.it.
authors.forename: Andrea
authors.initials: A
authors.lastname: Frustaci
authors.affiliation: From the Department of Cardiovascular, Respiratory, Nefrologic and Geriatric Sciences, La Sapienza University, Rome, Italy (A.F., C.C.); and Mebic Consortium, San Raffaele University, Rome, Italy (M.A.R.).
authors.forename: Matteo A
authors.initials: MA
authors.lastname: Russo
authors.affiliation: From the Department of Cardiovascular, Respiratory, Nefrologic and Geriatric Sciences, La Sapienza University, Rome, Italy (A.F., C.C.); and Mebic Consortium, San Raffaele University, Rome, Italy (M.A.R.).
authors.forename: Cristina
authors.initials: C
authors.lastname: Chimenti
mesh_terms: D004252:DNA Mutational Analysis; D004351:Drug Resistance; D056947:Enzyme Replacement Therapy; D000795:Fabry Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics; D020022:Genetic Predisposition to Disease; D006801:Humans; D007527:Isoenzymes / Q000627:therapeutic use; D008297:Male; D008840:Microfilament Proteins / Q000235:genetics; D008875:Middle Aged; D009154:Mutation; D010641:Phenotype; D017211:Treatment Failure; D000519:alpha-Galactosidase / Q000235:genetics / Q000627:therapeutic use*
chemical_list: D007527:Isoenzymes; D008840:Microfilament Proteins; C501659:NEXN protein, human; C576330:GLA protein, human; D000519:alpha-Galactosidase
keywords: Fabry disease; atenolol; biopsy; cell size; dyspnea